08:02
creatine
A physician who recommends creatine to patients and family explains why he personally has not taken it and may never take it: his family carries a genetic kidney disease (polycystic kidney disease), and because no safety data exist for creatine supplementation in people with pre-existing kidney disease, his personal risk/benefit calculation comes out differently than it does for most healthy people, for whom he says the evidence is favorable.
The presenter states he takes no sponsors and sells no creatine-related products, framing this as the reason he can evaluate the data objectively with no conflict of interest.
A systematic review and meta-analysis of randomized trials found creatine supplementation increased fat-free mass by an average of 0.8 kilos while reducing body fat percentage by roughly 0.28%, with effects strengthening when paired with resistance training.
Creatine increases strength, including in older adults and in people with muscle conditions like muscular dystrophies.
Vegetarians and vegans may benefit more from supplementation because their diets naturally contain less creatine, which is richest in meat and seafood.
Creatine may help performance and recovery by activating cells that help heal exercise-induced muscle micro-tears, and most ingested creatine goes straight to muscle tissue to help fuel and re-energize it.
Creatine may improve short-term memory, reasoning, attention, and information-processing speed, an effect seen more often and more strongly in older individuals, and in younger people mainly under stress conditions like sleep deprivation.
A proposed mechanism for the cognitive effect is that creatine supplies ATP energy to neurons; younger adults have higher baseline creatine and mitochondrial efficiency, leaving less room for supplementation to help, while older adults or stressed individuals have lower baseline levels and see a bigger effect.
A randomized trial found diabetics receiving creatine supplementation lowered their hemoglobin A1C and post-meal blood sugar levels.
Creatine is inexpensive, costing a couple of dollars a month when supplemented daily.
A main safety concern is that creatine converts partly into creatinine, the same marker used to measure kidney function, so supplementation can artificially raise creatinine readings and make kidney function look worse than it is.
There is also a concern that excreting the extra creatinine could place an added burden on the kidneys and potentially damage them over time.
Studies ranging from 5 days to 5 years, at doses from 5 to 30 grams a day, show no measurable effect on kidney function indices like glomerular filtration rate (GFR) — but these studies were conducted in healthy individuals with no pre-existing kidney disease.
The presenter has a family history of polycystic kidney disease (PKD), a genetically inherited condition causing fluid-filled cysts to grow slowly in the kidneys, usually asymptomatic until the 60s or 70s, when it can progress to kidney failure requiring dialysis or a transplant.
There is little to no safety data on creatine supplementation in people with any kidney disease, and specifically none, as far as the presenter knows, for polycystic kidney disease.
The presenter's personal strategy is to avoid creatine and instead pursue the same benefits through other means: working out harder for slower but comparable muscle/fat results, careful sleep/rest/diet/exercise for cognitive support, and diet/exercise for glucose control.
Overall conclusion stated in the video: for healthy people without kidney issues, especially older individuals and those who work out, the risk/benefit of creatine is favorable and worth considering.
The kidney-safety debate around creatine is partly a measurement-artifact problem: creatinine is used as the standard biomarker for kidney function, but creatine supplementation itself raises creatinine levels, so an elevated reading can look like kidney dysfunction even when the kidneys are fine.
The presenter's personal abstention is explicitly framed as absence-of-evidence-driven caution rather than evidence-of-harm: he states there is no data at all on creatine safety in PKD, not that there is data showing risk.
He treats creatine's benefits as substitutable by effort and time rather than unique: the muscle/fat and glucose-control benefits can, in his account, be obtained through harder training and stricter lifestyle discipline, just on a longer timeline — reducing his personal opportunity cost of skipping the supplement.
The age/stress-dependent efficacy pattern he describes (bigger cognitive benefit in older or sleep-deprived people, smaller in young rested people) is attributed to baseline creatine and mitochondrial efficiency levels, implying the supplement mainly compensates for a deficit rather than boosting performance above a normal baseline.
«Creatine is one of the most studied supplements on the planet.»
— 00:00
«I don't sell creatine. I don't have a connection to any company that does.»
— 00:36
«A systematic review and meta analysis of randomized trials found that creatine supplementation increased fat-free mass by an average of 0.8 kilos while at the same time reducing body fat percentage by roughly 0.28%.»
— 01:09
«this suggests that creatine is not making you superhuman but it's supporting your brain activity.»
— 03:25
«There's also a concern that excreting that extra creatinine might be an extra burden on your kidneys and over time may damage them or harm them somehow.»
— 04:46
«specifically on polycystic kidney we have no data as far as I know.»
— 06:27
«my strategy personally, you can see this is very personal, is to play it safe until we know more about creatine supplementation, specifically in a population that has kidney issues.»
— 07:22
Reception
Strong positive reception centered on creator credibility and scientific integrity, with the highest-engagement comment praising willingness to correct and cite sources, though some viewers express kidney safety concerns.
The video presents creatine as well-evidenced and broadly favorable in risk/benefit terms for healthy people, while using the presenter's own family history of polycystic kidney disease — and the total absence of safety data for that specific population — to illustrate that the same evidence base can justify a different individual choice.
08:02